Submission of the Risk Assessment form by a health care professional is required to determine a child's eligibility for palivizumab. Risk Assessment forms available on the RSV Prevention Risk Prevention Program website.
Public transportation available
Children under the age of 2 with underlying medical conditions considered high risk for severe RSV disease.
Healthcare providers should consult the Alberta Referral Directory for service referral information.